Page last updated: 2024-08-22

rhenium and Cancer of Prostate

rhenium has been researched along with Cancer of Prostate in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.64)	18.7374
1990's	25 (40.98)	18.2507
2000's	25 (40.98)	29.6817
2010's	10 (16.39)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arrowsmith, RL; Benny, PD; Botchway, SW; Clegg, W; Davies, LH; Ge, H; Harrington, RW; Higham, LJ; Kasten, BB; Pascu, SI	1
Benny, PD; Bu, L; Cheng, K; Cheng, Z; Hayes, TR; Kasten, BB; Ma, X; Slocumb, WS; Trabue, S	1
Brust, P; Chen, X; Chen, Y; Deuther-Conrad, W; Dong, C; Jia, B; Jia, H; Li, D; Liu, B; Steinbach, J; Wang, X	1
de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bosma, TB; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bergmann, R; Geidel, HH; Haase, M; Kotzerke, J; Liepe, K; Runge, R	1
Benny, PD; Bucar, DK; Macgillivray, LR; Moore, AL	1
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A	1
Banerjee, S; Dhyani, MV; Korde, A; Satpati, D	1
O'Sullivan, JM; Parker, CC; Vengalil, S	1
Cui, L; Jia, B; Jin, X; Li, F; Liu, Z; Wang, F	1
Chao, CH; Chen, MC; Hsu, FN; Huang, CY; Lin, E; Lin, H; Lin, T; Lin, WY; Luo, TY; Wang, HY	1
Babich, JW; Eckelman, WC; Hillier, SM; Joyal, JL; Lu, G; Maresca, KP; Zimmerman, CN	1
Douard, MC; George, B; Rain, JD	1
Blijham, GH; de Klerk, JM; Derksen, BH; Han, SH; Kruitwagen, CL; Tan, S; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
McCready, VR; O'Sullivan, JM	1
Buffa, FM; Chittenden, SJ; Dearnaley, DP; Flux, GD; Guy, MJ; McCready, VR; O'Sullivan, JM	1
Franke, WG; Hliscs, R; Knapp, FF; Kropp, J; Liepe, K; Runge, R	1
Albers, P; Biersack, HJ; Ezziddin, S; Fimmers, R; Guhlke, S; Joe, A; Knapp, FF; Manka-Waluch, A; Palmedo, H; Reinhardt, M; Roedel, R; Schmidt-Wolf, IG	1
Kotzerke, J; Kropp, J; Liepe, K; Runge, R	1
Buffa, FM; Coffey, J; Cook, G; Dearnaley, DP; Flux, G; Horwich, A; Huddart, RA; Johnson, B; McCready, VR; Norman, AR; O'Sullivan, JM; Parker, CC; Treleaven, J	1
Adams, S; Baum, RP; Breidert-Backes, I; Hör, G	1
Bloch, G; Chittenden, S; Dearnaley, DP; Divoli, A; Flux, GD; Malaroda, A; O'Sullivan, JM	1
Gildehaus, FJ; Göke, B; Morris, JC; Senekowitsch-Schmidtke, R; Sharif Samani, BR; Spitzweg, C; Stark, HJ; Willhauck, MJ; Wolf, I	1
Koutsikos, J; Leondi, A	1
Fujihiro, S; Fujimoto, Y; Isogai, K; Kanamori, I; Kuriyama, M; Matsuo, S; Nishiura, T; Takeuchi, T; Yasuda, E; Yoshida, H	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Cosmatos, D; Eisbruch, A; Garcia, DM; Perez, CA; Poulter, CA	1
Blijham, GH; de Klerk, JM; Han, SH; Stokkel, MP; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Hoekstra, A; Rutgers, DH; van Dieren, EB; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Bender, H; Biersack, HJ; Diekmann, D; Gulhke, S; Knapp, FF; Rhodes, BA; Zamora, PO	1
Silberstein, EB	1
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P	1
Blijham, GH; de Klerk, JM; Krouwer, HG; van Die, J; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; ten Kroode, HF; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Geldof, AA; Newling, DW; Teule, GJ; van den Tillaar, PL	1
Botha, JM; Doman, MJ; Goedhals, L; Lötter, MG; Marais, J; Naudé, H; Otto, AC; Roodt, A; van Aswegen, A	1
Biersack, HJ; Dierke-Dzierzon, C; Müller, SC; Palmedo, H; Schoeneich, G	1
Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M	1
Blower, PJ; Coakley, AJ; Kettle, AG; Knapp, FF; Lam, AS; O'Doherty, MJ	1
Lerch, H	1
de Rooij, L; Geldof, AA; Newling, DW; Teule, GJ; Versteegh, RT	1
Curley, T; Daghighian, F; Goldsmith, SJ; Graham, MC; Larson, SM; Liu, GB; Scher, HI; Yeh, SD	1
de Klerk, JM; Huiskes, AW; van Dijk, A; van Het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Brans, B; De Winter, F; Dierckx, RA; Van De Wiele, C	1
Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Knapp, FF; Palmedo, H; Risse, J; Sartor, J; Schoeneich, G	1
Csernay, L; Láng, J; Pajor, L; Pávics, L; Róka, R; Séra, T; Thurzó, L	1
Bohuslavizki, KH; Klutmann, S	1
Abrahamsson, PA; Ahlgren, G; Darte, L; Flodgren, P; Garkavij, M; Strand, SE; Tennvall, J	1
Blower, PJ; Coakley, AJ; Kettle, AG; Knapp, FF; O'Doherty, MJ	1
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A	1
Carpentier, P; Caty, A; Depreux, P; Kolesnikov-Gauthier, H; Sulman, C; Vennin, P	1
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R	1
Franke, WG; Hliscs, R; Kropp, J; Liepe, K	1
Bestagno, M; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A; Pizzocaro, C	1
Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A	1
Al-Deen, A; Buffa, FM; Chittenden, S; Cook, G; Dearnaley, DP; Flux, G; Gadd, J; Guy, M; Horwich, A; Huddart, RA; McCready, VR; Norman, AR; O'Sullivan, JM; Pomeroy, K; Treleaven, J	1
Curley, T; Larson, S; O'Moore, PV; Scher, HI; Tong, W; Yeh, S	1
de Klerk, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Deutsch, EA; Hertzberg, VS; Libson, KF; Maxon, HR; Moulton, JS; Samaratunga, RC; Scher, HI; Schroder, LE; Thomas, SR; Williams, CC	1
Ehrhardt, GJ; Englaro, EE; Hertzberg, VS; Maxon, HR; Moulton, JS; Samaratunga, R; Schroder, LE; Smith, H; Thomas, SR; Williams, CC	1

Reviews

3 review(s) available for rhenium and Cancer of Prostate

Article	Year
Use of radionuclides in metastatic prostate cancer: pain relief and beyond. Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:3 Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium	2012
[Metabolic radiotherapy: what role will it have in 2001?]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2002, Volume: 6, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome	2002
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992

Trials

24 trial(s) available for rhenium and Cancer of Prostate

Article	Year
(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Capecitabine; Deoxycytidine; Drug Resistance, Neoplasm; Etidronic Acid; Fluorouracil; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Radiopharmaceuticals; Rhenium	2009
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:9 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tin Radioisotopes	2002
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8 Topics: Body Burden; Bone Marrow; Bone Neoplasms; Computer Simulation; Etidronic Acid; Humans; Injections, Intravenous; Male; Models, Biological; Organometallic Compounds; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Rhenium; Statistics as Topic; Treatment Outcome; Whole-Body Counting	2003
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Aged; Aged, 80 and over; Body Burden; Bone Marrow; Bone Neoplasms; Etidronic Acid; Half-Life; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiation Dosage; Radiometry; Rhenium; Tissue Distribution; Urinary Bladder; Whole-Body Counting	2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Aged; Bone Neoplasms; Disease Progression; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Rhenium; Treatment Outcome	2003
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4 Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2003
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:9 Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Peripheral Blood Stem Cell Transplantation; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Transplantation, Autologous	2006
Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:1 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Rhenium; Tomography, Emission-Computed, Single-Photon	2007
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer. European journal of nuclear medicine, 1994, Volume: 21, Issue:10 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Thrombocytopenia	1994
Irradiation in relapsing carcinoma of the prostate. Cancer, 1993, Feb-01, Volume: 71, Issue:3 Suppl Topics: Bone Neoplasms; Brachytherapy; Brain Neoplasms; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Phosphorus Radioisotopes; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Spinal Cord Compression; Strontium Radioisotopes	1993
Dosage and response in radiopharmaceutical therapy of painful osseous metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Male; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1996
[Pain therapy with rhenium-186 HEDP in multiple bone metastases]. Nuklearmedizin. Nuclear medicine, 1996, Volume: 35, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed	1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:9 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Time Factors	1996
Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results. Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:5 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1997
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:6 Topics: Androgens; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Whole-Body Counting	1999
Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP? Nuclear medicine communications, 1999, Volume: 20, Issue:9 Topics: Aged; Blood Platelets; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Organometallic Compounds; Organotechnetium Compounds; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Thrombocytopenia	1999
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. European journal of nuclear medicine, 2000, Volume: 27, Issue:2 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Pain Measurement; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium	2000
[Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain]. Orvosi hetilap, 2000, May-07, Volume: 141, Issue:19 Topics: Alkaline Phosphatase; Analgesics; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2000
Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Time Factors	2000
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed	2000
Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes; Tin Radioisotopes	2001
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. British journal of cancer, 2002, Jun-05, Volume: 86, Issue:11 Topics: Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Etidronic Acid; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organometallic Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiotherapy; Recombinant Proteins; Rhenium	2002
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:10 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Technetium Tc 99m Medronate	1991

Other Studies

35 other study(ies) available for rhenium and Cancer of Prostate

Article	Year
Re and (99m)Tc complexes of BodP3--multi-modality imaging probes. Chemical communications (Cambridge, England), 2014, Dec-21, Volume: 50, Issue:98 Topics: Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Fluorescent Dyes; Humans; Male; Models, Molecular; Multimodal Imaging; Optical Imaging; Phosphines; Prostatic Neoplasms; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon	2014
Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer. Bioconjugate chemistry, 2016, Jan-20, Volume: 27, Issue:1 Topics: Animals; Cell Line, Tumor; Chelating Agents; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Organotechnetium Compounds; Peptides; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Urokinase Plasminogen Activator; Rhenium; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays	2016
(99m)Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging. Journal of medicinal chemistry, 2016, Feb-11, Volume: 59, Issue:3 Topics: Animals; Cell Line, Tumor; Chelating Agents; Glioma; Humans; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Molecular Conformation; Neoplasms; Organometallic Compounds; Prostatic Neoplasms; Receptors, sigma; Rhenium; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays	2016
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP. Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:1 Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes	2009
Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer. Nuclear medicine communications, 2009, Volume: 30, Issue:9 Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Etidronic Acid; Lumbar Vertebrae; Male; Osteoblasts; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Tissue Distribution	2009
"Click" labeling strategy for M(CO)(3) (M = Re, (99m)Tc) prostate cancer targeted flutamide agents. Dalton transactions (Cambridge, England : 2003), 2010, Feb-28, Volume: 39, Issue:8 Topics: Crystallography, X-Ray; Flutamide; Humans; Isotope Labeling; Male; Molecular Conformation; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Androgen; Rhenium; Technetium; Triazoles	2010
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2011
Synthesis and preliminary bioevaluation of 99mTc(CO)3-17α-triazolylandrost-4-ene-3-one derivative prepared via click chemistry route. Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:5 Topics: Androsterone; Animals; Cell Line, Tumor; Click Chemistry; Humans; Male; Organotechnetium Compounds; Prostatic Neoplasms; Radionuclide Imaging; Rats; Rats, Wistar; Rhenium; Tissue Distribution; Triazoles	2011
Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy. Nuclear medicine and biology, 2013, Volume: 40, Issue:2 Topics: Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Dipeptides; Humans; Male; Mice; Oligopeptides; Prostatic Neoplasms; Radiochemistry; Radioisotopes; Radiometry; Radionuclide Imaging; Receptors, Peptide; Rhenium	2013
Inhibitory effects of Rhenium-188-labeled Herceptin on prostate cancer cell growth: a possible radioimmunotherapy to prostate carcinoma. International journal of radiation biology, 2013, Volume: 89, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 5; Humans; Isotope Labeling; Male; Mice; Prostatic Neoplasms; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Receptors, Androgen; Rhenium; Trastuzumab; Xenograft Model Antitumor Assays	2013
Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates. Bioorganic & medicinal chemistry letters, 2013, Mar-01, Volume: 23, Issue:5 Topics: Cell Line, Tumor; Chelating Agents; Humans; Kallikreins; Ligands; Male; Organotechnetium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Structure-Activity Relationship; Tissue Distribution	2013
New approaches to the use of unsealed source radionuclide therapy for skeletal metastases. Kaku igaku. The Japanese journal of nuclear medicine, 2002, Volume: 39, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Rhenium	2002
[Unusual, unilateral metastasis of a prostate-carcinoma and palliative rhenium-186 pain-therapy]. Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:8 Topics: Aged, 80 and over; Functional Laterality; Humans; Male; Neoplasm Metastasis; Pain; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	1997
Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:11 Topics: Adult; Animals; Cell Line, Tumor; Cell Survival; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation, Neoplastic; Half-Life; Humans; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Rhenium; Symporters; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2007
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2008
[Clinical evaluation of prostatic lymphoscintigraphy]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1983, Volume: 74, Issue:9 Topics: Aged; Evaluation Studies as Topic; Humans; Lymph Nodes; Male; Middle Aged; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Radionuclide Imaging; Rhenium; Technetium; Technetium Compounds	1983
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Middle Aged; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1994
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1 Topics: Aged; Bone Marrow; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Palliative Care; Platelet Count; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Rhenium; Thrombocytopenia	1996
Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue. International journal of cancer, 1996, Jan-17, Volume: 65, Issue:2 Topics: Adenocarcinoma; Animals; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Radioisotopes; Receptors, Somatostatin; Rhenium; Somatostatin; Transplantation, Heterologous	1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:3 Topics: Bone Neoplasms; Cranial Nerve Diseases; Etidronic Acid; Glossopharyngeal Nerve; Humans; Hypoglossal Nerve; Male; Mandibular Nerve; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1996
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model. Urology, 1997, Volume: 49, Issue:5 Topics: Animals; Etidronic Acid; Lumbar Vertebrae; Male; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Spinal Neoplasms; Survival Rate	1997
Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study. Nuclear medicine communications, 1997, Volume: 18, Issue:6 Topics: Adult; Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Papio; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tissue Distribution; Urinary Bladder	1997
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)]. Der Urologe. Ausg. A, 1997, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium	1997
Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. European journal of nuclear medicine, 1998, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Animals; Bone Neoplasms; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Succimer; Tissue Distribution	1998
[Advanced prostate carcinoma: systemic radionuclide therapy of bone metastasis with rhenium-168-hydroxyethylidine diphosphonate]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1998, Volume: 174, Issue:7 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1998
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:4 Topics: Animals; Cisplatin; Combined Modality Therapy; Drug Screening Assays, Antitumor; Etidronic Acid; Male; Organometallic Compounds; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Rats; Rhenium; Tumor Cells, Cultured	1999
Visualization of the stomach on rhenium-186 HEDP imaging after therapy for metastasized prostate carcinoma. Clinical nuclear medicine, 1999, Volume: 24, Issue:11 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Stomach	1999
[Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]. MMW Fortschritte der Medizin, 1999, Nov-04, Volume: 141, Issue:44 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1999
Palliative radiation with a radiolabeled diphosphonate (rhenium-186 etidronate) in patients with hormone-refractory disseminated prostate carcinoma. Scandinavian journal of urology and nephrology, 2000, Volume: 34, Issue:3 Topics: Bone Neoplasms; Humans; Male; Pain Management; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Analysis; Technetium Tc 99m Medronate; Treatment Outcome	2000
99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. European journal of nuclear medicine, 2000, Volume: 27, Issue:9 Topics: Aged; Bone Neoplasms; Humans; Male; Middle Aged; Phantoms, Imaging; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid	2000
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Annals of nuclear medicine, 2000, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium	2000
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy. Clinical nuclear medicine, 2000, Volume: 25, Issue:11 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	2000
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. European journal of nuclear medicine, 2001, Volume: 28, Issue:7 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes	2001
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:5 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Half-Life; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium	1992
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology, 1990, Volume: 176, Issue:1 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Estrogens; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Rhenium; Tin	1990